Clackson, Tim
Xilio Therapeutics,
United States
2024 Rank: 62012
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2592 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62012 | 69386 |
| Total Cites | 11010 | 12007 |
| H-index | 46 | 48 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 253 | 265 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 2878 | 2935 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 4734 | 4933 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8511 | 9002 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
8.30%
|
|
Clackson, Tim
Takeda Pharmaceutical Company Limited,
United States
2023 Rank: 58401
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2489 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58401 | 65130 |
| Total Cites | 10431 | 11407 |
| H-index | 45 | 48 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 251 | 263 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2811 | 2868 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 4577 | 4776 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8056 | 8531 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
8.56%
|
|
Clackson, Tim
ARIAD Pharmaceuticals, Inc.,
United States
2022 Rank: 55401
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2384 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55401 | 61620 |
| Total Cites | 9698 | 10642 |
| H-index | 43 | 46 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 243 | 255 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2724 | 2781 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 4368 | 4565 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7500 | 7955 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
8.87%
|
|
Clackson, Tim
ARIAD Pharmaceuticals, Inc.,
United States
2021 Rank: 52966
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2297 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52966 | 58943 |
| Total Cites | 9324 | 10241 |
| H-index | 43 | 46 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 241 | 253 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 2661 | 2717 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 4234 | 4427 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7206 | 7642 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
8.95%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.